Morning Alertness & Beyond: An Opportunity for Bacognize®
- 07 May 2026
- Written by LEHVOSS Nutrition
European data consistently shows that the transition from sleep to wake represents a period of reduced alertness and cognitive efficiency, making morning cognitive readiness a highly scientifically validated optimisation window for ingredient innovation1.
Research on Bacognize®, a clean-label, standardised extract of Bacopa monnieri, has shown improvements in morning alertness, emotional wellbeing and perceived health status, alongside further positive effects on sleep-related parameters, including reduced grogginess upon waking2.
Additional findings indicate improvements in stress-related biomarkers3, supporting its role in both daytime cognitive performance and restorative sleep quality. Research also suggests that Bacognize® may interact with serotonergic pathways.
These are involved in serotonin and melatonin regulation3, supporting its role in cognitive performance, emotional stability and sleep–wake cycle regulation.
Alongside its cognitive and circadian research, Bacognize® is supported by a programme focused on community cultivation, farmer support and process efficiency. Seasonal cultivation activities employ 30-80 labourers and benefit 50-60 families. Polyhouse drying technology reduces drying time by 50%, improves processing efficiency and helps reduce fungal contamination. A community farmer group manages cultivation activities while 250 MT of storage capacity helps maintain year-round supply and reduce post-harvest losses.
For more information, download the Bacognize® Product Profile Sheet here or contact us.
References
(1) Cassie J Hilditch & Andrew W McHill (2019) Sleep inertia: current insights, Nature and Science of Sleep, 155-165, DOI:10.2147/NSS.S188911
(2) Lopresti A et al. Effects of a Bacopa monnieri extract (Bacognize®) on stress, fatigue, quality of life and sleep in adults with self-reported poor sleep: A randomised, double-blind, placebo-controlled study. Journal of Functional Foods, Volume 85, October 2021, 104671.
(3) Hall et al. Pharmacology of Bacopa monnieri (Bacognize®) at 5HT1a and 5HT2a receptors. Am Soc Pharmacog Absts. 2005. 83-85. Poster presentation in 46th Am Soc Pharmacog (ASP) Annual Meeting, Corvallis, OR.



Developing cognitive health products for different life stages means addressing diverse consumer...
Creatine has long been associated with
Join LEHVOSS Italia at In-Vitality (Allianz MiCo - Milano Convention Centre, 25-26 November) to...
As demand for marine lipids and innovation continues to grow, the industry is placing greater... 




































